in vitro evaluation of 66 epidemiologically distinct , gentamicin-resistant , gram-negative isolates from four hospitals revealed that 92 % were kanamycin resistant , 44 % were netilmicin resistant , 41 % were tobramycin resistant , and 6 % were amikacin resistant .
C0022487
kanamycin
C0002499
amikacin